A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

NCT01248949 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Advanced Recurrent Ovarian Tumors

Interventions

DRUG: MEDI3617
DRUG: Bevacizumab
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

MedImmune LLC